Evidence map›Paper›PMID 28191316›Full record

ArticleBasic and clinical andrology2017

The contraceptive efficacy of intravas injection of Vasalgel™ for adult male rhesus monkeys.

Angela Colagross-Schouten, Marie-Josee Lemoy, Rebekah I Keesler, Elaine Lissner, Catherine A VandeVoort

Open access · goldAbstract read
In one paragraph

Article in Basic and clinical andrology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
5.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 36 citations in OpenAlex.

  1. Trial
  2. Novel male contraceptives.Future science OA · 2026
    Review
  3. Review
  4. Review
  5. Non-hormonal Contraception: Current and Emerging Targets.Advances in experimental medicine and biology · 2025
    Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Emerging approaches to male contraception.Fertility and sterility · 2021
    Review
  11. Update on Novel Hormonal and Nonhormonal Male Contraceptive Development.The Journal of clinical endocrinology and metabolism · 2021
    Review
  12. Male Contraception.The Yale journal of biology and medicine · 2020
    Review
  13. Development of Novel Male Contraceptives.Clinical and translational science · 2020
    Review
  14. Review
  15. Article
  16. The future of male contraception: a fertile ground.Translational andrology and urology · 2018
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Angela Colagross-SchoutenCalifornia National Primate Research, University of California, One Shields Ave, Davis, CA 95616 USA.
Marie-Josee LemoyCalifornia National Primate Research, University of California, One Shields Ave, Davis, CA 95616 USA.
Rebekah I KeeslerCalifornia National Primate Research, University of California, One Shields Ave, Davis, CA 95616 USA.
Elaine LissnerParsemus Foundation, PO Box 2246, Berkeley, CA 94702 USA.
Catherine A VandeVoortCalifornia National Primate Research, University of California, One Shields Ave, Davis, CA 95616 USA.
University of California, Davis · US

Funding

National Institute on Aging (NIA) ColonyP51OD011107 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Simon J. Atkinson · 2012 to 2026
$191.5M
NIH HHS P51 OD011107
6 · The paper itself

Abstract

backgroundOptions for male contraception are limited. The purpose of this study was to use a nonhuman primate model to evaluate Vasalgel™, a high molecular weight polymer being developed as a contraceptive device for men.

methodsSixteen adult male rhesus monkeys received intravas injections of Vasalgel, consisting of 25% styrene maleic acid in dimethyl sulfoxide. After a one-week recovery, males were returned to outdoor group housing, which included at least 3 and up to 9 intact, breeding females with a successful reproductive history.

resultsTreated males have had no conceptions since Vasalgel injections. All males were housed with intact females for at least one breeding season and seven have been almost continually housed with females for 2 years. Complications were minor and included one incident of incorrect placement of Vasalgel into the vas deferens and the development of a sperm granuloma in one animal. Three unilateral vasectomies were performed, one was necessary for incorrect placement of Vasalgel, the other two were elective.

conclusionsIntravas injection of Vasalgel in sexually mature adult male rhesus monkeys was effective in preventing conception in a free-living, group environment. Complications were few and similar to those associated with traditional vasectomy.

Indexed as

Colony managementContraceptionFertilityHydrogelMacaca mulattaPrimateSterilizationStyrene maleic acid polymerVasalgelVas deferensVasectomy

Identifiers

PMID28191316
PMCPMC5294830
OpenAlexW2580383005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.